Clinical Trials List
2023-06-01 - 2026-06-08
Phase III
Recruiting4
ICD-10D89.82
Autoimmune lymphoproliferative syndrome [ALPS]
ICD-10D89.89
Other specified disorders involving the immune mechanism, not elsewhere classified
ICD-9279.4
Autoimmune disease, not elsewhere classified
xxxxxx
-
Sponsor
xxxxxx
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/11/13
Investigators and Locations
Co-Principal Investigator
- 張哲慈 Division of Rheumatology
- 陳彥輔 Division of Rheumatology
- Ping-Han Tsai Division of Rheumatology
- Shue-Fen Lo Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 歐燦騰 風濕免疫科
- Chia-Chun Tseng 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林科宏 Division of Rheumatology
- Tzn-Min Lin Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Hsing Chen Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
- 陳彥如 Division of Rheumatology
- 廖育婉 Division of Rheumatology
- 林靖才 Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- 謝祖怡
- 高宗楙 Division of Rheumatology
- 顏在弘 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
621 participants
